Evidence map›Paper›PMID 36556134›Full record

ArticleJournal of clinical medicine2022

Hypokalemia Duration in the First Year Associated with Subsequent Peritoneal Dialysis-Associated Peritonitis: A Multicenter Retrospective Cohort Study.

Zhihao Huo, Qianqian Zhuo, Shaoxin Zhong, Fang Wang, Chao Xie, Nirong Gong, Xiaohong Zhong, Zhixiu Yi, Yaozhong Kong, Dehui Liu and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Zhihao HuoDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0003-3135-9350
Qianqian ZhuoDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Shaoxin ZhongDepartment of Nephrology, Shunde Hospital, Southern Medical University, Foshan 528308, China.
Fang WangDepartment of Nephrology, Nanfang Hospital, Ganzhou (Ganzhou People's Hospital), Ganzhou 341000, China.
Chao XieNephrology Department, The First People's Hospital of Foshan, Foshan 528000, China.
Nirong GongDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Xiaohong ZhongDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhixiu YiDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yaozhong KongNephrology Department, The First People's Hospital of Foshan, Foshan 528000, China.
Dehui LiuDepartment of Nephrology, Nanfang Hospital, Ganzhou (Ganzhou People's Hospital), Ganzhou 341000, China.
Xianrui DouDepartment of Nephrology, Shunde Hospital, Southern Medical University, Foshan 528308, China.
Guobao WangDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jun AiDivision of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.ORCID 0000-0002-2876-2475
Nanfang Hospital · CNFirst People's Hospital of Foshan · CNGanzhou People's Hospital · CNThe First People's Hospital of Shunde · CN

Funding

Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education LC2019ZD002National Nature Science Foundation of China 81870489Nature and Science Foundation of China 81770765Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University 2017J013
6 · The paper itself

Abstract

backgroundThe association of hypokalemia (LK) with peritoneal dialysis-associated peritonitis (PDAP) risk remains uncertain. Here, we calculated LK duration in the first PD year and evaluated its association with PDAP.

methodsA multicenter, retrospective, incident cohort study of 1633 participants was conducted from January 2008 to October 2020 in China. The duration of LK and severe hypokalemia (SLK) was calculated as the total number of months that a patient's serum potassium (SK) level was less than 3.5 or 3.0 mEq/L during the first PD year. The study outcome was the risk of subsequent PDAP started in the second year and later. Cox proportional hazards models and competing risk models were used to assess the association.

resultsThe subsequent PDAP occurred in 420 (25.7%) participants during a median of 28 months of follow-up. Overall, LK duration in the first year was positively associated with a subsequent PDAP risk (per 3-month increments, adjusted HR, 1.13; 95%CI: 1.05-1.23). After categorization, patients with LK duration longer than 6 months had the highest adjusted HR of 1.53 (

conclusionsPD patients with longer LK duration in the first year had a higher subsequent PDAP risk.

Indexed as

hypokalemia durationperitoneal dialysis-associated peritonitissevere hypokalemia

Identifiers

PMID36556134
PMCPMC9783936
OpenAlexW4312140797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.